Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Clinical trial NCT07485114 · RECRUITING

Trial details

NCT number: NCT07485114
Sponsor: Daniel Keizman
Status: RECRUITING
Study type: OBSERVATIONAL

Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung Cancer Hepatocellular Carcinoma Transitional Cell Carcinoma

Start date: 2025-12-03
Primary completion: 2028-12-03
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.